Efrain G.

Founders and regulated companies usually do not need more regulations explained to them. They need clarity on what they can do, what creates real regulatory or quality risk, and what needs to happen next. I help founders, QA/RA leaders, pharmaceutical, biotech, medical device and regulated technology companies turn complex Quality and Regulatory requirements into practical, defensible and audit ready solutions. With 20+ years of experience in pharmaceutical and biotech Quality Assurance and Quality Systems, I support organizations across FDA, EMA, MHRA, EU MDR and global GxP environments. My work typically focuses on four areas: • QMS & GMP Compliance QMS design and remediation, CAPA, deviations, change control, SOPs, supplier quality, audit readiness and inspection preparation. • 21 CFR Part 11 & Digital Quality Systems CSV, SaaS validation, IQ/OQ/PQ, requirements traceability, audit trails, electronic signatures, access controls, eQMS, ELN and LIMS. • FDA & Medical Device Regulatory Strategy Regulatory assessments, 510(k) readiness, intended use, claims, labeling, technical documentation and market-readiness gaps. • FDA Market & Product Compliance Labeling and claims reviews, dietary supplements, import and FSVP related compliance, cosmetics and regulated product market entry. Clients typically engage me when they need answers to questions such as: • Can we launch, sell or scale this product compliantly? • Is our current regulatory or quality approach defensible? • What are the real gaps in our QMS, validation package or technical documentation? • What needs to be fixed before an audit, inspection, submission or market launch? • Are we overengineering compliance or missing something critical? • Can our current systems and documentation support the next stage of growth? My approach is risk based and execution focused. I do not overcomplicate compliance or produce documentation simply for the sake of documentation. I identify the gaps that matter, prioritize risk, define the practical next steps and deliver clear, usable outputs that can withstand regulatory, quality and client review. I work especially well with: • Founders and leadership teams building regulated products or entering regulated markets • QA and Regulatory Affairs leaders who need senior external expertise • Pharmaceutical and biotech companies strengthening Quality Systems • Medical device and health technology companies preparing for FDA or EU requirements • SaaS and technology providers supporting regulated GxP environments The objective is simple: give you enough regulatory and quality clarity to make the right decision and move forward without unnecessary complexity. If you have a product, system, validation package, regulatory question or compliance risk, send me the context and I can quickly determine the right scope and next step.